eTheRNA immunotherapies
Develops immunotherapies that target the fundamental role of dendritic cells in the human immune system. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€156—234m (Dealroom.co estimates Aug 2022.)
Company register number 0502.703.389
Antwerp Province of Antwerp (HQ)
Authorizing premium user...